Emerging evidence for CHFR as a cancer biomarker: from tumor biology to precision medicine

Novel insights in the biology of cancer have switched the paradigm of a “one-size-fits-all” cancer treatment to an individualized biology-driven treatment approach. In recent years, a diversity of biomarkers and targeted therapies has been discovered. Although these examples accentuate the promise o...

Descripción completa

Detalles Bibliográficos
Autores principales: Derks, Sarah, Cleven, Arjen H. G., Melotte, Veerle, Smits, Kim M., Brandes, Johann C., Azad, Nilofer, van Criekinge, Wim, de Bruïne, Adriaan P., Herman, James G., van Engeland, Manon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2013
Materias:
Non-Thematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3988518/
https://www.ncbi.nlm.nih.gov/pubmed/24375389
http://dx.doi.org/10.1007/s10555-013-9462-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3988518/
https://www.ncbi.nlm.nih.gov/pubmed/24375389
http://dx.doi.org/10.1007/s10555-013-9462-4

Ejemplares similares